1. Home
  2. ONC vs DOV Comparison

ONC vs DOV Comparison

Compare ONC & DOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONC
  • DOV
  • Stock Information
  • Founded
  • ONC 2010
  • DOV 1947
  • Country
  • ONC Switzerland
  • DOV United States
  • Employees
  • ONC N/A
  • DOV N/A
  • Industry
  • ONC Biotechnology: Pharmaceutical Preparations
  • DOV Industrial Machinery/Components
  • Sector
  • ONC Health Care
  • DOV Industrials
  • Exchange
  • ONC Nasdaq
  • DOV Nasdaq
  • Market Cap
  • ONC 26.9B
  • DOV 23.7B
  • IPO Year
  • ONC N/A
  • DOV N/A
  • Fundamental
  • Price
  • ONC $245.58
  • DOV $177.65
  • Analyst Decision
  • ONC Strong Buy
  • DOV Buy
  • Analyst Count
  • ONC 7
  • DOV 12
  • Target Price
  • ONC $326.43
  • DOV $211.33
  • AVG Volume (30 Days)
  • ONC 368.4K
  • DOV 954.8K
  • Earning Date
  • ONC 05-07-2025
  • DOV 07-24-2025
  • Dividend Yield
  • ONC N/A
  • DOV 1.16%
  • EPS Growth
  • ONC N/A
  • DOV 59.80
  • EPS
  • ONC N/A
  • DOV 16.60
  • Revenue
  • ONC $4,180,740,829.00
  • DOV $7,728,249,000.00
  • Revenue This Year
  • ONC $32.78
  • DOV $4.05
  • Revenue Next Year
  • ONC $19.07
  • DOV $4.60
  • P/E Ratio
  • ONC N/A
  • DOV $23.70
  • Revenue Growth
  • ONC 52.09
  • DOV 3.19
  • 52 Week Low
  • ONC $141.31
  • DOV $143.04
  • 52 Week High
  • ONC $287.88
  • DOV $222.31
  • Technical
  • Relative Strength Index (RSI)
  • ONC N/A
  • DOV 49.88
  • Support Level
  • ONC N/A
  • DOV $176.70
  • Resistance Level
  • ONC N/A
  • DOV $182.13
  • Average True Range (ATR)
  • ONC 0.00
  • DOV 2.81
  • MACD
  • ONC 0.00
  • DOV -0.63
  • Stochastic Oscillator
  • ONC 0.00
  • DOV 12.62

About ONC BeiGene Ltd. American Depositary Shares

Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeiGene runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeiGene's revenue.

About DOV Dover Corporation

Founded in 1955 by George Ohrstrom, Dover has become an industrial behemoth through the acquisition of dozens of esteemed brands. The company is organized into five segments through which it designs and manufactures highly engineered components, such as vehicle repair, factory automation, welding, aerospace, fuel dispensing, printing, liquid handling, refrigeration, and can-making equipment. It has operations around the globe but generates over half of its revenue in the United States.

Share on Social Networks: